Case of the week 12/2019


Use of CytoSorb in a patient with septic-cardiogenic shock after TAVI and MitraClip implantation
Dr. L.-U. Kühne, Prof. Dr. F.-C. Rieß, Dipl-Ing. R. Binczyk | Cardiosurgical Intensive Care Unit, Cardiovascular Centre, Albertinen Hospital, Hamburg, Germany

This report describes the case of an 84-year-old patient who was admitted to the emergency department due to dyspnea with subsequent transfer to the internal/cardiology intensive care unit due to respiratory failure.


The Therapy

An extracorporeal blood purification therapy to reduce excessive inflammation mediators

The Fields of Application

Treat septic shock & severe sepsis on ICU, prevent SIRS in cardiac surgery patients

The Studies

Current multi- and monocentric study projects in Europe and US, an international registry, case series

The Adsorber

A cutting edge bead technology turns CytoSorb into the only specifically approved extracorporeal cytokine adsorber

CytoSorb registry

Become part of the International CytoSorb registry!

For the first time treatment data, courses of treatment and results of a new treatment are systematically recorded according to highest scientific standards.